Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.5200
+0.0153 (3.04%)
At close: May 12, 2025, 4:00 PM
0.5200
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT
Xtant Medical Holdings Revenue
In the year 2024, Xtant Medical Holdings had annual revenue of $117.27M with 28.44% growth. Xtant Medical Holdings had revenue of $31.51M in the quarter ending December 31, 2024, with 12.11% growth.
Revenue (ttm)
$117.27M
Revenue Growth
+28.44%
P/S Ratio
0.59
Revenue / Employee
$505,461
Employees
232
Market Cap
72.44M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.27M | 25.96M | 28.44% |
Dec 31, 2023 | 91.30M | 33.33M | 57.50% |
Dec 31, 2022 | 57.97M | 2.71M | 4.90% |
Dec 31, 2021 | 55.26M | 1.93M | 3.61% |
Dec 31, 2020 | 53.34M | -11.35M | -17.54% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
XTNT News
- 7 hours ago - Xtant Medical Reports First Quarter 2025 Financial Results - PRNewsWire
- 6 days ago - Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025 - PRNewsWire
- 19 days ago - Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance - PRNewsWire
- 26 days ago - Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19% - PRNewsWire
- 2 months ago - Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results - Accesswire
- 2 months ago - Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025 - Accesswire
- 6 months ago - Xtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha